BRISTOL MYERS SQUIBB CO (BMY)
Healthcare · Pharmaceutical Preparations
BRISTOL MYERS SQUIBB CO (BMY) stock research on InvestAtlant: institutional ownership from 13F filings, insider Form 4 activity, and SEC context.
Top institutional holders (2026-Q3)
| Institution | Shares | Value | % Outstanding |
|---|---|---|---|
| PZENA INVESTMENT MANAGEMENT LLC | 14,244,839 | $888.88M | — |
| Robeco Institutional Asset Management B.V. | 7,200,298 | $449.30M | — |
| DekaBank Deutsche Girozentrale | 5,862,955 | $368.7K | — |
| Sumitomo Mitsui Trust Group, Inc. | 5,072,993 | $316.55M | — |
| KBC Group NV | 4,227,911 | $263.8K | — |
| Artemis Investment Management LLP | 2,823,235 | 76.17M | — |
| Mirae Asset Global Investments Co., Ltd. | 2,769,316 | — | — |
| Swedbank AB | 2,472,114 | 54.26M | — |
Recent insider transactions
| Date | Insider | Title | Type | Value |
|---|---|---|---|---|
| 2026-09-09 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | Sale | $403.5K |
| 2026-08-25 | Holzer Phil M | SVP and Controller | Sale | $33.8K |
| 2026-04-01 | Elkins David V | EVP, Chief Financial Officer | Sale | .57M |
| 2026-04-01 | Elkins David V | EVP, Chief Financial Officer | Sale | $278.0K |